logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Panmira Pharmaceuticals, LLC

Calculating rank
USPTO Granted Patents = 23

% Expired Patents = 95.7



Forward Citations = 98

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal John Howard Hutchinson (20 out of 112 patents)

silverMedal Brian Andrew Stearns (14 out of 36 patents)

bronzeMedal Nicholas Simon Stock (11 out of 37 patents)

4.  Jeannie M Arruda (9 out of 28 patents)

5.  Yen Truong (8 out of 17 patents)

6.  Thomas Jon Seiders (7 out of 31 patents)

7.  Jeffrey Roger Roppe (7 out of 29 patents)

8.  Bowei Wang (5 out of 26 patents)

9.  Jill Melissa Scott (5 out of 9 patents)

10.  Deborah Volkots (4 out of 13 patents)

11.  Jillian Frances Evans (3 out of 9 patents)

12.  Mark Moran (3 out of 12 patents)

13.  Yiwei Li (3 out of 9 patents)

14.  Petpiboon Peppi Prasit (3 out of 13 patents)

15.  Kevin Schaab (2 out of 5 patents)


23 patents:

1. 8841295 - 5-lipoxygenase-activating protein (FLAP) inhibitors (2014-09-23),
2. 8815917 - DP2 antagonist and uses thereof (2014-08-26),
3. 8785393 - Ophthalmic pharmaceutical compositions of DP2 receptor antagonists (2014-07-22),
4. 8772495 - 5-lipoxygenase-activating protein inhibitor (2014-07-08),
5. 8710081 - 5-lipoxygenase-activating protein (FLAP) inhibitors (2014-04-29),
6. 8697730 - 5-lipoxygenase activating protein (FLAP) inhibitor (2014-04-15),
7. 8546431 - 5-lipoxygenase-activating protein (FLAP) inhibitors (2013-10-01),
8. 8524748 - [object Object] (2013-09-03),
9. 8501959 - [object Object] (2013-08-06),
10. 8497381 - [object Object] (2013-07-30),
11. 8426449 - Aminoalkylphenyl antagonists of prostaglandin D2 receptors (2013-04-23),
12. 8399666 - 5-lipoxygenase-activating protein (FLAP) inhibitors (2013-03-19),
13. 8383654 - [object Object] (2013-02-26),
14. 8378107 - [object Object] (2013-02-19),
15. 8362044 - N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors (2013-01-29),
Company Overview
Panmira Pharmaceuticals, LLC is a biotechnology company based in San Diego, California, focused on developing innovative therapies for unmet medical needs. The organization specializes in the research and development of novel treatments, particularly in the fields of oncology and autoimmune diseases. By leveraging advanced scientific methodologies and a commitment to improving patient outcomes, Panmira aims to bring transformative solutions to the healthcare landscape, addressing critical challenges in disease management.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

23 Patents

#263 in San Diego, CA

#3,424 in California

#14,450 in US

#27,736 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Panmira Pharmaceuticals, LLC

Forward Citations = 98

23 inventors:

goldMedal John Howard Hutchinson (20 out of 112 patents)

silverMedal Brian Andrew Stearns (14 out of 36 patents)

bronzeMedal Nicholas Simon Stock (11 out of 37 patents)

4.  Jeannie M Arruda (9 out of 28 patents)

5.  Yen Truong (8 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Panmira Pharmaceuticals, LLC. Retrieved from https://idiyas.com/company/panmira-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…